143 related articles for article (PubMed ID: 28990092)
1. Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival.
Guo L; Zheng J; Yu T; Liu Y; Duo L
Mol Med Rep; 2017 Dec; 16(6):8842-8848. PubMed ID: 28990092
[TBL] [Abstract][Full Text] [Related]
2. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of RPA3 Is Involved in Gastric Cancer Tumorigenesis and Associated with Poor Patient Survival.
Dai Z; Wang S; Zhang W; Yang Y
Dig Dis Sci; 2017 Sep; 62(9):2369-2375. PubMed ID: 28766245
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
5. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
6. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
10. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
12. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1.
Sun Z; Zhang C; Zou X; Jiang G; Xu Z; Li W; Xie H
Mol Med Rep; 2015 May; 11(5):3235-542. PubMed ID: 25586771
[TBL] [Abstract][Full Text] [Related]
13. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
14. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.
Bertoli G; Cava C; Diceglie C; Martelli C; Rizzo G; Piccotti F; Ottobrini L; Castiglioni I
Breast Cancer Res Treat; 2017 Feb; 161(3):605-616. PubMed ID: 28000015
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
Bo H; Gao L; Chen Y; Zhang J; Zhu M
Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
[TBL] [Abstract][Full Text] [Related]
18. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L
Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
